Nanoparticle‑based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review)
International Journal of Oncology · 19.08.2025 · 67 (4) · 1-15
DOI: 10.3892/ijo.2025.5789 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 19.08.2025. Verfasst von Jing-Xing Si und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, …. Hauptthemen laut MEDLINE: Brain Neoplasms, Nanoparticle Drug Delivery System, Drug Delivery Systems, Nanoparticles. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Brain tumors, particularly gliomas, are among the most lethal malignancies, with high mortality driven by a delayed diagnosis and limited therapeutic efficacy. A central challenge lies in the presence of the blood‑brain barrier (BBB), which severely impedes the delivery of systemically administered therapeutics to tumor sites. Addressing this clinical urgency, nanoparticle (NP)‑based delivery systems have emerged as a transformative strategy to enhance brain‑specific drug accumulation, minimize off‑target toxicity and improve treatment outcomes. The present review systematically examined the recent advances in nanocarrier technologies for targeted brain tumor therapy, including liposomes, solid lipid NPs, dendrimers, polymeric nanoplatforms and inorganic nanomaterials. The design principles, mechanisms for BBB traversal, therapeutic payload compatibility and tumor‑targeting capabilities of NP technologies demonstrated in preclinical models have also been highlighted. In addition to drug delivery, emerging applications of nanocarriers in gene therapy were explored and the impact of protein corona formation on NP behavior in vivo was discussed. Finally, current translational bottlenecks were identified and future design considerations to achieve clinically viable, precision‑targeted nanomedicines for brain tumors were outlined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China.
- Department of Paediatrics, Center for Reproductive Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China.
Zitieren
APA
Si, J. X., Liu, Z. C., Gu, F., Jin, X., & Ma, Y. Y. (2025). Nanoparticle‑based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review). International Journal of Oncology, 67(4), 1-15. https://doi.org/10.3892/ijo.2025.5789
Vancouver
Si JX, Liu ZC, Gu F, Jin X, Ma YY. Nanoparticle‑based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review). International Journal of Oncology. 2025;67(4):1-15. doi:10.3892/ijo.2025.5789
BibTeX
@article{Si2025,
author = {Si, Jing-Xing and Liu, Zheng-Chuang and Gu, Fang and Jin, Xiaoli and Ma, Ying-Yu},
title = {Nanoparticle‑based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review)},
journal = {International Journal of Oncology},
year = {2025},
volume = {67},
number = {4},
pages = {1--15},
doi = {10.3892/ijo.2025.5789}
}
EUVIMED